European Pharmaceutical Review

JANUARY 11, 2023

Machine learning models used to guide the design of long-acting injectable drug formulations have been successfully tested by scientists at the University of Toronto. Once we had the data set, we split it into two subsets: one used for training the models and one for testing. Achieving slow-release drug formulation.

Side effects 113

Side effects Training Pharmaceutical Networking 113

European Pharmaceutical Review

JANUARY 2, 2024

The report recommened that to gain a competitive edge in the market, focusing on modernising R&D models or implementing emerging technologies could support this endeavour. The pharmaceutical industry will need to innovate and increase resilience to accelerate market expansion, the company highlighted.

Pharma 78

Pharma Medicine Government Marketing 78

European Pharmaceutical Review

APRIL 28, 2023

NEW, FLEXIBLE, data-driven manufacturing models are emerging to address the pharmaceutical industry’s need for greater operational efficiency. Throughout the report, and this article, readers will see that while objectives vary, the common factor in all innovation journeys is the importance of data integrity.

Pharma 91

Pharma Pharmaceutical manufacturing Manufacturing Pharmaceutical 91

Pharmacy Times

OCTOBER 16, 2023

Investigators created a model to predict asthma exacerbations that can be integrated in WhatsApp chatbot and relies on self-reported data.

52

52

Medico Reach

DECEMBER 15, 2022

These are software applications that analyze the collected information from a range of sources, including but not limited to clinical research, operational activity, patient care programs and financial reports. IBM SPSS Modeler. This article looks at four of the most prominent solutions available. CareDirector by Allscripts.

Healthcare 98

Healthcare Healthcare Marketing Customer Relationship Management 98

pharmaphorum

JANUARY 12, 2023

The deal with the tech giant’s Google Cloud unit revolves around its tensor processing units (TPUs), artificial intelligence-powered accelerators designed to run machine learning models and computationally-intensive workloads that can be customised to specific applications.

Medicine 119

Medicine Pharma Sales Healthcare 119

European Pharmaceutical Review

NOVEMBER 1, 2022

Reporting in ACS’ Nano Letters , about the condition androgenic alopecia , the researchers explained that hair follicles can be damaged by androgens, inflammation or an overabundance of reactive oxygen species, such as oxygen free radicals. However, so far, those that have been reported are not very good at removing oxygen free radicals.

Transportation 91

Transportation Pharmaceutical 91

World of DTC Marketing

FEBRUARY 21, 2022

To quantify the equilibrium price effects of coupons, they employed individual-level data to estimate a discrete choice model of demand for multiple sclerosis drugs. Pfizer’s Paxlovid currently costs about $530 for a five-day course of the treatment. Merck’s molnupiravir, now approved for use in the U.K., costs about $700.

Pharma 218

Pharma Competition Manufacturing Medicine 218

European Pharmaceutical Review

SEPTEMBER 12, 2023

Initial data from the CPHI Annual Report 2023, which provides insight from 250 global pharmaceutical companies, reveals that AI (artificial intelligence) is expected to transform every area of the industry, from drug discovery through to drug development , within the next 24-months. Attending CPHI Barcelona 2023?

Food and Drug Administration 97

Food and Drug Administration Manufacturing FDA Pharmaceutical 97

European Pharmaceutical Review

JUNE 2, 2023

stated that to their knowledge, the study represents the first time that pH has been incorporated into a metabolic model. It represents a paradigm shift from a traditional, inflexible, validation-based manufacturing model to one that is based on comprehensive scientific and engineering understanding of bioprocesses. For instance.

Manufacturing 90

Manufacturing Engineering Medicine Pharmaceutical 90

Clarivate

MARCH 6, 2024

2024 report key findings Samsung Electronics ranks first in the Top 100 Global Innovators 2024. See more analysis from the 2024 report here. Within the report we pinpoint the organizations leading the innovation ecosystem. Innovation intelligence capitalizes on powerful data models and techniques to improve IP decision-making.

Electronics 52

Electronics Competition Media Leads 52

European Pharmaceutical Review

JULY 20, 2023

Research published in Processes has reported the first successful establishment, validation and integration of a digital twin with process analytical technology (PAT) operated autonomously for biologics manufacturing. A model was developed from flow and coalescence models. Validation was carried out for both: In 97.5

Manufacturing 60

Manufacturing Training Pharmaceutical 60

European Pharmaceutical Review

FEBRUARY 27, 2023

Due to more biopharmaceutics classification system (BCS) II and BCS IV molecules being evaluated in early development, a market report has signalled that the bioavailability enhancement market will grow at a steady rate between 2022 to 2035. These were specifically for small molecules intended for oral drug delivery.

Marketing 83

Marketing Distribution Pharmaceutical Competition 83

Copyright Clearance Center

JULY 18, 2023

and Europe to understand their OA reporting needs and outline an ideal solution together. The conversations resulted in CCC’s adoption of the European Statistical Advisory Committee (ESAC) Article List, an OA agreement reporting template which has become a powerful reference for data sharing practices in support of the move to OA.

Media 98

Media Management Marketing Leads 98

European Pharmaceutical Review

APRIL 16, 2024

Biosimilars market A report published by Towards Healthcare noted that the biosimilar market has grown “rapidly” in the past few years, chiefly because of the benefits of these products being a cost-effective alternative to the reference product.

Healthcare 79

Healthcare Healthcare Manufacturing Marketing 79

World of DTC Marketing

DECEMBER 22, 2021

Strategies can be proposed to mitigate the major delays and disruptions and standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review.”

Patients 241

Patients Doctors Healthcare Healthcare 241

European Pharmaceutical Review

JUNE 22, 2023

While non-compartmental analysis provides an unbiased data evaluation, mechanistic compartmental models such as the physiologically-based nanocarrier biopharmaceutics model have potential in offering improved sensitivity and resolving causes of inequivalence. percent between the two formulation prototypes. percent (low versus high).

Distribution 82

Distribution Pharmaceutical Medicine Leads 82

European Pharmaceutical Review

SEPTEMBER 29, 2022

According to a new report , implementing a Transferable Exclusivity Extension (TEE) system could solve the “broken economic model” for researching and developing new antibiotics in Europe. Supporting and enabling surgical interventions. Reducing transmission of infections. Productivity gains from enabling patients to get back to work.

Medicine 104

Medicine Healthcare Healthcare Patients 104

pharmaphorum

AUGUST 31, 2022

The alliance will also build on the existing machine-learning model in melanoma and apply it to new models for other indications and treatments, he added. It is also working with MSD Germany on a project to develop artificial intelligence-enabled DPPM for lung cancer patients, and with Amgen on modules for multiple myeloma.

Patients 112

Patients Electronics Management Pharma 112

PM360

OCTOBER 28, 2022

According to a Deloitte report , pharmaceutical investment ROI has declined from 10.1% Although we’re still at the beginning of the AI revolution in pharma, promising use-cases have already been identified: Drug discovery: In drug discovery , AI models are predicting the 3D structure of target proteins at an unprecedented scale.

Pharma 105

Pharma Food and Drug Administration Government Medicine 105

European Pharmaceutical Review

JUNE 8, 2023

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation.

Biopharma 81

Biopharma Government Training Education 81

Pharmaceutical Technology

MARCH 9, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Transgenic murine models. Regeneron Pharmaceuticals is the leading patent filer in transgenic murine models. Sanofi and F.

Leads 52

Leads Pharmaceutical Engineering Marketing 52

European Pharmaceutical Review

MAY 3, 2023

A market report has shown that the digital biomanufacturing market is anticipated to grow at a compound annual growth rate (CAGR) of 11 percent between 2023-2035, driven largely by digital transformation. The report also identified that the rising popularity of cloud-based technologies is expected to capture a large portion of the market.

Marketing 91

Marketing Manufacturing Biopharma Competition 91

pharmaphorum

SEPTEMBER 9, 2022

Meanwhile, 36% said recruitment and enrolment of subject into trials were also improved, with patients reporting better experiences with participation, and almost all (99.7%) thought that all or some improvements to the clinical trial process as a result of the pandemic will be here to stay.

Recruitment 96

Recruitment Professional Services Patients 96

PharmExec

AUGUST 1, 2022

Citing strong reporting results, hybrid model to continue supplementing on-site inspections.

FDA 52

FDA 52

Clarivate

JUNE 29, 2023

At Clarivate, we curate billions of proprietary best-in-class data assets which feed our machine, deep learning and large language models to power our insights, services and workflow solutions. Who owns the models? How can companies ensure that their data doesn’t fall into the hands of competitors through large language models?

Patients 98

Patients Safety Healthcare Healthcare 98

Pharmaceutical Technology

JUNE 6, 2023

It decreased vitamin A dimerization by more than 80% and prevented blindness in a genetic animal model of the disease in preclinical trials. Gildeuretinol is the first and only medicine in clinical development to treat Stargardt disease by reducing vitamin A dimerization in the eye, without affecting normal vision.

Food and Drug Administration 111

Food and Drug Administration Food Pharmaceutical Medicine 111

Pharmaceutical Technology

JUNE 6, 2023

GlobalData uses proprietary data and analytics to provide a complete picture of PF-06835375’s valuation in its risk-adjusted NPV model (rNPV). Buy the model here. The revenue for PF-06835375 is expected to reach an annual total of $16 mn by 2039 in the US based off GlobalData’s Expiry Model. over FY2021. in FY2021.

Retail 40

Retail Manufacturing Government Pharmaceutical 40

Clarivate

NOVEMBER 23, 2023

Briefly covered in our Companies to Watch 2023 report, which spotlights seven innovators changing the drug discovery and development paradigm, we will delve deeper into these best practices here. High-quality data for AI models is key to achieving high-quality insights.

Marketing 52

Marketing Management Government Consulting 52

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Genetically modified animal models. However, not all innovations are equal and nor do they follow a constant upward trend.

Leads 52

Leads Pharmaceutical FDA Marketing 52

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: IgG gene expressing animal models. Regeneron Pharmaceuticals is the leading patent filer in IgG gene expressing animal models.

Leads 52

Leads Pharmaceutical Engineering Marketing 52

European Pharmaceutical Review

JULY 7, 2023

The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally. The Imperial College London report highlighted the UK is faced with a dramatic slowdown in its rate of economic growth.

Competition 85

Competition Biopharma Government Manufacturing 85

Pharmaceutical Technology

MAY 9, 2023

The deals will add digital chemistry predictive models and further deep learning capabilities to Recursion’s artificial intelligence (AI)-enabled drug discovery platform. increase on Monday 8 when the acquisitions were announced compared to the previous Friday, the company has reported a $65.3m for Cyclica and Valence respectively.

Pharmaceutical 52

Pharmaceutical 52

Clarivate

APRIL 3, 2024

The impact of AI A recent Clarivate global survey of IP and R&D professionals revealed that 43% reported AI is not currently used in their practice, with 64% expecting minimal change to their role due to AI and 49% citing the lack of AI regulation as a concern. Special Report: Redefining Artificial Intelligence.

Management 59

Management Specialization Training Government 59

Pharmaceutical Technology

NOVEMBER 25, 2022

Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData's latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition’.

Healthcare 145

Healthcare Healthcare Digital Media Media 145

PM360

FEBRUARY 1, 2024

According to a McKinsey report , a startling 40% of biopharma products fail to meet their sales forecasts within the initial two years, prompting a critical reassessment of strategies for product launches. Traditional models are simply not getting the job done.

Biopharma 59

Biopharma Competition Prescription Education 59

Pharmaceutical Technology

FEBRUARY 23, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Artificial Intelligence in Pharmaceuticals: In-silico drug discovery. However, not all innovations are equal nor do they follow a constant upward trend.

Leads 75

Leads Pharmaceutical Engineering Healthcare 75